YTE reported $221K in Ordinary Share Capital for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ordinary Share Capital Change
Acadia Pharmaceuticals ACAD:US $ 0.02M 0M
Agenus AGEN:US $ 2.67M 0.1M
Agios Pharmaceuticals AGIO:US $ 0.07M 0M
Alnylam Pharmaceuticals ALNY:US $ 1.21M 0M
Amgen AMGN:US $ 31247M 849M
Biocryst Pharmaceuticals BCRX:US $ 1.86M 0.01M
Biogen BIIB:US $ 0.1M 0M
Biomarin Pharmaceutical BMRN:US $ 0.18M 0M
Bluebird Bio BLUE:US $ 0.71M 0M
Bristol Myers Squibb BMY:US $ 292M 0M
Cerulean Pharma CERU:US $ 0.01M 0M
Chemocentryx CCXI:US $ 0.07M 0M
Clovis Oncology CLVS:US $ 0.14M 0.02M
Cti Biopharma CTIC:US $ 0.1M 0M
Eli Lilly And LLY:US $ 594.1M 2.2M
Exelixis EXEL:US $ 0.32M 0M
Gilead Sciences GILD:US $ 1M 0M
Idera Pharmaceuticals IDRA:US $ 0.05M 0M
Intercept Pharmaceuticals ICPT:US $ 0.03M 0M
IONIS PHARMACEUT IONS:US $ 0.14M 0M
Merk MRK:US $ 1788M 0M
Newlink Genetics NLNK:US $ 0.08M 0M
Novartis NOVN:VX SF 901M 0M
Novartis NVS:US $ 901M 0M
Ultragenyx Pharmaceutical RARE:US $ 0.07M 0M
YTE INCY:US $ 0.22M 0M